AI In Cancer Diagnostics Market Report 2026

AI In Cancer Diagnostics Market Overview

• AI In Cancer Diagnostics market size has reached to $0.79 billion in 2025 • Expected to grow to $1.97 billion in 2030 at a compound annual growth rate (CAGR) of 19.9% • Growth Driver: Rising Cancer Cases Propel Advances Artificial Intelligence Takes Center Stage In Cancer Diagnostics • Market Trend: AI-Driven Pathology Solutions Transform Cancer Diagnosis in Europe • North America was the largest region in 2025.

What Is Covered Under AI In Cancer Diagnostics Market?

AI in cancer diagnostics refers to the use of artificial intelligence technologies, such as machine learning and deep learning, to analyze medical images, genetic data, or patient histories to assist in the early detection, diagnosis, and prognosis of cancer. These systems can recognize patterns and anomalies in data that might be imperceptible to humans, increasing diagnostic accuracy and efficiency. The main types of components of AI in cancer diagnostics are software solutions, hardware, and services. Software solutions refer to the use of artificial intelligence (AI) and machine learning (ML) technologies to improve the accuracy and efficiency of cancer detection, prognosis, and treatment selection. The various types of cancer include breast cancer, lung cancer, brain tumor, skin cancer and cervical cancer, prostate and colorectal cancer, and others. These are used in various applications such as screening and diagnosis, tumor identification, and monitoring and also by various end users such as hospitals, diagnostic centers, medical research institutes, and contract research organizations.

What Is The AI In Cancer Diagnostics Market Growth Forecast?

The ai in cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $1.97 billion in 2030 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to advancements in deep learning and machine learning algorithms, growth of ai-powered imaging systems, increasing integration of predictive analytics in healthcare, rising investments in digital health technologies, collaboration between ai developers and medical institutions. Major trends in the forecast period include growing adoption of AI-based imaging and diagnostic tools, integration of predictive analytics in cancer screening, rising use of ai for tumor identification and classification, expansion of AI-driven monitoring and follow-up systems, increasing collaboration between hospitals and ai solution providers.

Global AI In Cancer Diagnostics Market Segmentation

1) By Component: Software Solutions, Hardware, Services 2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types 3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring 4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes Subsegments: 1) By Software Solutions: Machine Learning Software, Deep Learning Software, Image Analysis Software 2) By Hardware: AI-Powered Imaging Systems, Diagnostic Devices 3) By Services: AI Integration Services, Consulting And Training Services, Support And Maintenance Services

What Is The Driver Of The AI In Cancer Diagnostics Market?

The increasing prevalence of cancer is expected to propel the growth of artificial intelligence in the cancer diagnostics market going forward. Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. The integration of AI in cancer care aims to enhance efficiency, accuracy, and personalized treatment options, ultimately improving outcomes for cancer patients. For instance, in May 2024, according to the National Cancer Institute, a US-based Government agency, In 2024, approximately 2 million new cancer cases are expected to be diagnosed in the U.S., with over 611,000 deaths projected. By 2040, new cancer cases are estimated to rise to 29.9 million globally, with cancer-related deaths increasing to 15.3 million. Therefore, the increasing prevalence of cancer is driving the growth of artificial intelligence in the cancer diagnostics market.

Key Players In The Global AI In Cancer Diagnostics Market

Major companies operating in the ai in cancer diagnostics market are Microsoft Corporation, IBM Corporation, Verily Life Sciences LLC, Tempus Labs Inc, Guardant Health Inc, Lunit Inc, Paige AI Inc, Viz.ai Inc, Enlitic Inc, Ibex Medical Analytics Ltd, Kheiron Medical Technologies Limited, CureMetrix Inc, CancerIQ Inc, MultiplAI Health Inc, Freenome Holdings Inc, SkinVision B V, Owkin Inc, Imagen Technologies Inc, Cyrcadia Health Inc, Oncora Medical Inc, Xilis Inc

Global AI In Cancer Diagnostics Market Trends and Insights

Major companies operating in the AI in cancer diagnostics market are experiencing significant growth due to advancements in AI-powered digital pathology solutions for cancer diagnosis. AI-powered digital pathology solutions for cancer diagnosis refer to the use of artificial intelligence (AI) algorithms to detect cancer and other diagnostic features in multiple tissue types, providing accurate and timely cancer diagnosis, support case prioritization, and reproducible diagnoses. For instance, In November 2023, Dedalus & Ibex Medical Analytics, a Europe-based health software company, launched an integrated End-to-End AI-powered digital pathology solution for cancer diagnosis across Europe. This solution aims to improve accuracy, provide AI-powered decision support tools, streamline reporting, enhance laboratory efficiency, and increase diagnostic confidence.

What Are Latest Mergers And Acquisitions In The AI In Cancer Diagnostics Market?

In December 2023, Lunit, a South Korean-based AI company, acquired Volpara for $193 million. This acquisition is expected to position the combined entity as a leading force in AI-driven cancer diagnostics, particularly in the U.S. market, due to Volpara's strong presence in over 2,000 medical sites across the U.S. and its extensive database of over 100 million high-quality mammogram images. The acquisition is contingent upon Volpara shareholders' and New Zealand High Court's approval. Volpara is a New Zealand-based company that provides AI-powered software for personalized screening and early detection of breast cancer.

Regional Outlook

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the AI In Cancer Diagnostics Market?

AI in the cancer diagnostics market consists of revenues earned by entities by providing services such as early detection and screening, image analysis and interpretation, predictive analytics, and treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in Cancer Diagnostics market also consists of sales of medical imaging devices, pathology analysis systems, genomic sequencing equipment, and patient monitoring devices that are used in providing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the AI In Cancer Diagnostics Market Report 2026?

The ai in cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ai in cancer diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.